ATE543504T1 - Hox peptide als pbx-modulatoren zur behandlung von krebs - Google Patents

Hox peptide als pbx-modulatoren zur behandlung von krebs

Info

Publication number
ATE543504T1
ATE543504T1 AT06755670T AT06755670T ATE543504T1 AT E543504 T1 ATE543504 T1 AT E543504T1 AT 06755670 T AT06755670 T AT 06755670T AT 06755670 T AT06755670 T AT 06755670T AT E543504 T1 ATE543504 T1 AT E543504T1
Authority
AT
Austria
Prior art keywords
amino acid
absent
side chain
sequence
amino acids
Prior art date
Application number
AT06755670T
Other languages
English (en)
Inventor
Richard George Morgan
Jastinder Sohal
Original Assignee
St Georges Entpr Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Georges Entpr Ltd filed Critical St Georges Entpr Ltd
Application granted granted Critical
Publication of ATE543504T1 publication Critical patent/ATE543504T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT06755670T 2005-06-29 2006-06-28 Hox peptide als pbx-modulatoren zur behandlung von krebs ATE543504T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69513605P 2005-06-29 2005-06-29
PCT/GB2006/002390 WO2007000601A2 (en) 2005-06-29 2006-06-28 Gene regulation

Publications (1)

Publication Number Publication Date
ATE543504T1 true ATE543504T1 (de) 2012-02-15

Family

ID=37595498

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06755670T ATE543504T1 (de) 2005-06-29 2006-06-28 Hox peptide als pbx-modulatoren zur behandlung von krebs

Country Status (5)

Country Link
US (1) US20090286738A1 (de)
EP (1) EP1909811B1 (de)
JP (1) JP2009500314A (de)
AT (1) ATE543504T1 (de)
WO (1) WO2007000601A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2748009A1 (en) * 2008-12-23 2010-07-01 Vivoscript, Inc. Compositions and methods for re-programming cells without genetic modification
GB2543550A (en) 2015-10-21 2017-04-26 Hox Therapeutics Ltd Peptides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE333465T1 (de) * 1996-05-08 2006-08-15 Cyclacel Ltd Methoden und mittel zur hemmung der cdk4- aktivität
CA2337574C (en) * 2000-02-23 2013-01-22 Institut De Recherches Cliniques De Montreal/Ircm Hematopoietic stem cell expansion enhancing factor and method of use
GB0229151D0 (en) * 2002-12-13 2003-01-15 St Georges Entpr Ltd Product and method

Also Published As

Publication number Publication date
WO2007000601A3 (en) 2007-05-18
WO2007000601A8 (en) 2008-03-27
EP1909811B1 (de) 2012-02-01
JP2009500314A (ja) 2009-01-08
WO2007000601A2 (en) 2007-01-04
US20090286738A1 (en) 2009-11-19
EP1909811A2 (de) 2008-04-16

Similar Documents

Publication Publication Date Title
EA201170878A1 (ru) Полипептиды с ксиланазной активностью
HK1105982A1 (en) Antimicrobial peptides comprising an arginine-and/or lysine-containing motif
MX2010002460A (es) Complejos de arn y peptidos cationicos para transfeccion y para inmunoestimulacion.
WO2004078777A3 (en) Dipeptidyl-peptidase protected proteins
AR108277A2 (es) Péptidos inhibidores de fusión de hiv con propiedades biológicas mejoradas
NZ602170A (en) Modified leptin polypeptides and their uses
BRPI0714336A2 (pt) utilizaÇço de um hidrolisado de proteÍnas de arroz como princÍpio ativo pigmentante.
TW200722436A (en) A peptide-immunoglobulin-conjugate
EP2789626A3 (de) Peptide und Zusammensetzungen zur Prävention von Zellenadhäsion und Verfahren zu deren Verwendung
WO2007029262A3 (en) Compositions and methods using same for the detection of viruses
CY1109631T1 (el) Χρησιμοποιηση πεπτιδιων, τα οποια εχουν παραχθει απο την αα- ή ββ-αλυσιδα του ανθρωπινου ινωδογονου, για τη θεραπεια σοκ
WO2008113536A8 (en) Neurotrophic peptides
SG10201803541TA (en) Biologically active c-terminal arginine-containing peptides
ATE543504T1 (de) Hox peptide als pbx-modulatoren zur behandlung von krebs
WO2008047370A3 (en) Compositions and methods for inducing angiogenesis
WO2007034490A3 (en) Diastereomeric peptides for modulating t cell immunity
WO2010057275A8 (en) Cyclic peptides and uses thereof
Centeno et al. Lactoferricin-related peptides with inhibitory effects on ACE-dependent vasoconstriction
DE60336846D1 (de) Peptide, welche die pbx abhängige genregulation beeinträchtigen
WO2010100569A3 (en) Natural biodegradable adhesive from the silk
WO2007066018A3 (fr) Peptides qui peuvent se lier a la proteine nef et leurs applications pharmaceutiques
EA201290384A1 (ru) Вирусные цитруллинированные пептиды и их применение
WO2008099928A1 (ja) 蛋白質分解酵素活性を調節する作用を有する胎盤蛋白質及びその関連遺伝子
MX2018004930A (es) Peptidos.
SG170757A1 (en) Polypeptide having esterase activity and recombinant esterase and use thereof